Value stocks have historically outperformed during economic recoveries -- and these companies look poised to shine under the new administration.
Connect Biopharma Pursues $150 Million U.S. IPO Plan
TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced its launch of the first avai
South Korea's National Pension Service started investments in PG&E and Etsy, bought more Zoom stock, and sold most of its Teva position in the fourth quarter.
The largest generic drug manufacturer in the world can be bought for pennies on the dollar.

2 Stocks I'd Avoid at All Costs

06:30am, Saturday, 20'th Feb 2021
If you're looking for stability or growth, look elsewhere.
TEVA beats on fourth-quarter earnings and sales. It issues its financial guidance for 2021.

8 Cheap Stocks Under $20 That Could Double

09:05am, Thursday, 11'th Feb 2021
Even though the market has been on fire recently, that doesn't mean you're too late to pick up cheap stocks under $20 with 2x (or more) potential. The post 8 Cheap Stocks Under $20 That Could Double a
Feb.10 -- Teva Pharmaceutical Industries Ltd. Chief Executive Officer Kare Schultz discusses the company's plans to produce and distribute Covid-19 vaccines and says Teva is ready to settle thousan
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q4 2020 Results - Earnings Call Transcript
Teva Pharmaceuticals CEO Kare Schultz joins "Squawk on the Street" to discuss the rollout of Covid-19 vaccines in Israel. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:
TEVA beats earnings and sales for fourth-quarter 2020. It issues its financial guidance for 2021.

Teva's stock rallies 2% on earnings

07:48am, Wednesday, 10'th Feb 2021
Shares of Teva Pharmaceutical Industries Ltd. gained 2.7% in premarket trading on Wednesday after the drugmaker beat expectations for revenue and adjusted earnings per share in the final quarter of 20

Recap: Teva Pharmaceutical Q4 Earnings

07:16am, Wednesday, 10'th Feb 2021
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 9.68% over the past year to
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE